ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 95 filers reported holding ODONATE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $269,000 | -99.4% | 20,007 | -98.1% | 0.00% | -100.0% |
| Q2 2020 | $41,435,000 | +29.3% | 1,065,182 | -8.2% | 0.02% | 0.0% |
| Q1 2020 | $32,053,000 | -17.0% | 1,160,932 | -2.4% | 0.02% | +5.0% |
| Q4 2019 | $38,614,000 | +18.8% | 1,189,958 | -4.7% | 0.02% | +11.1% |
| Q3 2019 | $32,516,000 | -40.4% | 1,249,203 | -16.0% | 0.02% | -37.9% |
| Q2 2019 | $54,581,000 | +57.9% | 1,487,636 | -4.8% | 0.03% | +52.6% |
| Q1 2019 | $34,558,000 | +53.3% | 1,562,995 | -2.4% | 0.02% | +35.7% |
| Q4 2018 | $22,545,000 | -27.5% | 1,601,213 | -0.0% | 0.01% | -6.7% |
| Q3 2018 | $31,091,000 | -12.1% | 1,601,786 | -0.0% | 0.02% | -16.7% |
| Q2 2018 | $35,373,000 | +7.7% | 1,602,018 | +1.5% | 0.02% | +5.9% |
| Q1 2018 | $32,841,000 | -14.6% | 1,578,427 | +0.0% | 0.02% | -5.6% |
| Q4 2017 | $38,437,000 | – | 1,577,927 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 15,514,566 | $297,880,000 | 45.48% |
| Boxer Capital, LLC | 5,607,086 | $107,656,000 | 3.46% |
| Samsara BioCapital, LLC | 815,421 | $15,656,000 | 1.57% |
| GSA CAPITAL PARTNERS LLP | 148,148 | $2,844,000 | 0.46% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,211,728 | $23,265,000 | 0.38% |
| RTW INVESTMENTS, LP | 1,000,139 | $19,203,000 | 0.32% |
| Sio Capital Management, LLC | 75,500 | $1,450,000 | 0.30% |
| AlphaCentric Advisors LLC | 29,594 | $568,000 | 0.24% |
| Birchview Capital, LP | 20,000 | $384,000 | 0.22% |
| Aristides Capital LLC | 33,226 | $638,000 | 0.22% |